Page 790 - Cardiac Nursing

p7
/
009
A
009
2
qx
e 7
A
6
A
66
ara
Apt
3-7
A
0
A
A
d
0
3
1
32_
0-c
68.
0
4 A
LWB
LWB K34 0-c 32_ p7 5 3-7 68. qx d 3 0 / 0 6 / / 2 009 1 2:0 4 A M Pa g g e 7 66 Apt ara
LWBK340-c32_p7553-768.qxd 30/06/2009 12:04 AM Page 766 Aptara
K34
K34
A
A
A
Pa
2:0
2:0
M
A
68.
M
766 PA R T V / Health Promotion and Disease Prevention
72. Barrett-Connor, E., & Wingard, D. L. (1983). Sex differential in is- metformin prevent type 2 diabetes in Asian Indian subjects with im-
9
chemic heart disease mortality in diabetics: A prospective population- paired glucose tolerance (IDPP-1). Diabetologia, 49(2), 289–297.
9
based study. American Journal of Epidemiology, 118, 489–496. 94. The Diabetes Prevention Program Research, G. (2005). Impact of inten-
8
73. Manson, J. E., Colditz, G. A., Stampfer, M. J., et al. (1991). A prospec- sive lifestyle and metformin therapy on cardiovascular disease risk factors
tive study of maturity-onset diabetes mellitus and risk of coronary heart in the diabetes prevention program. Diabetes Care, 28(4), 888–894.
disease and stroke in women. Archives of Internal Medicine, 151, 95. Orchard, T. J., Temprosa, M., Goldberg, R., et al. (2005). The Effect of
1141–1147. metformin and intensive lifestyle intervention on the metabolic syn-
74. Khaw, K. T., & Barrett-Connor, E. (1986). Prognostic factors for mor- drome: The Diabetes Prevention Program Randomized Trial. Annals of
tality in a population-based study of men and women with a history Internal Medicine, 142(8), 611–619.
6
of heart disease. Journal of Cardiopulmonary Rehabilitation, 6, 96. National Institutes of Health (NIH). (1998). National Heart, Lung, and
6
474–480. Blood Institute (NHLBI). Clinical guidelines on the identification, evalua-
75. Wong, N. D., Cupples, L. A., Ostfeld, A. M., et al. (1989). Risk factors tion, and treatment of overweight and obesity in adults. Bethesda, MD:
for long-term coronary prognosis after initial myocardial infarction: The HHS, Public Health Service (PHS).
0
0
Framingham Study. American Journal of Epidemiology, 130, 469–480. 97. Ogden, C. L., Carroll, M. D., Curtin, L. R., et al. (2006). Prevalence of
76. Stone, P. H., Muller, J. E., Hartwell, T., et al. (1989). The effect of dia- overweight and obesity in the United States, 1999–2004. JAMA, 295(13),
5
5
betes mellitus on prognosis and serial left ventricular function after acute 1549–1555.
myocardial infarction: Contribution of both coronary disease and dias- 98. Van Itallie, T. B. (1985). Health implication of overweight and obesity in
tolic left ventricular dysfunction to the adverse prognosis. Journal of the the United States. Annals of Internal Medicine, 103, 983–988.
2
2
American College of Cardiology, 12, 49–57. 99. Barrett-Connor, E. L. (1985). Obesity, atherosclerosis, and coronary ar-
77. Abbott, R. D., Donahue, R. P., Kannell, W. B., et al. (1988). The impact tery disease. Annals of Internal Medicine, 103, 1010–1019.
of diabetes on survival following myocardial infarction in men vs. 100. Hubert, H. B., Feinleib, M., McNamara, P. M., et al. (1983). Obesity as
0
women: The Framingham Study. JAMA, 260, 3456–3460. an independent risk factor for cardiovascular disease: A 26-year follow-up
0
7
7
78. Stevens, R. J., Coleman, R. L., Adler, A. I., et al. (2004). Risk factors for of participants in the Framingham Heart Study. Circulation, 67, 968–977.
myocardial infarction case fatality and stroke case fatality in type 2 dia- 101. Hoffmans, M. D. A. F., Kromhout, D., & De Lezenne Coulander, C.
7
7
betes: UKPDS 66. Diabetes Care, 27(1), 201–207. (1989). Body mass index at the age of 18 and its effects on 32-yearmor-
79. Murcia, A. M., Hennekens, C. H., Lamas, G. A., et al. (2004). Impact tality from coronary heart disease and cancer. Journal of Clinical Epi-
of diabetes on mortality in patients with myocardial infarction and left demiology, 42, 513–520.
2
2
4
4
ventricular dysfunction. Archives of Internal Medicine, 164(20), 102. Flegal, K. M., Graubard, B. I., Williamson, D. F., et al. (2007). Cause-
2273–2279. specific excess deaths associated with underweight, overweight, and obe-
80. Yan, R. T., Yan, A. T., Tan, M., et al. (2006). Underuse of evidence-based sity. JAMA, 298(17), 2028–2037.
treatment partly explains the worse clinical outcome in diabetic patients 103. Keil, J. E., Sutherland, S. E., Knapp, R. G., et al. (1993). Mortality rates
with acute coronary syndromes. American Heart Journal, 152(4), 676–683. and risk factors for coronary disease in black as compared with white
9
81. Folsom, A. R., Szklo, M., Stevens, J., et al. (1997). A prospective study men and women. New England Journal of Medicine, 329, 73–78.
9
of coronary heart disease in relation to fasting insulin, glucose, and dia- 104. Willett, W. C., Manson, J. E., Stampfer, M. J., et al. (1995). Weight,
0
0
betes. Diabetes Care, 20, 935–942. weight changes, and coronary heart disease in women, risk within the
82. Rönnemaa, T., Kaakso, M., Pyörälä, K., et al. (1991). High fasting “normal” weight range. JAMA, 273, 461–465.
plasma insulin is an indicator of coronary heart disease in non–insulin- 105. Johnson, J. L., Heineman, E. F., Heiss, G., et al. (1986). Cardiovascular dis-
dependent diabetic patients and nondiabetic subjects. Arteriosclerosis and ease risk factors and mortality among black women and white women aged
Thrombosis, 11, 80–90. 40–64 years in Evans County, Georgia. American Journal of Epidemiology,
83. Perry, I. J., Wannamethee, S. G., Whincup, P. H., et al. (1996). Serum 123, 209–220.
insulin and incident coronary heart disease in middle-aged British men. 106. Stevens, J., Keil, J. E., Rust, P. F., et al. (1992). Body mass index and
4
4
American Journal of Epidemiology, 144, 224–234. body girths as predictors of mortality in black and white women. Archives
84. Kaplan, N. M. (1989). The deadly quartet: Upper-body obesity, glucose of Internal Medicine, 152, 1257–1262.
2
2
intolerance, hypertriglyceridemia, and hypertension. Archives of Internal 107. Newton, K. M., & LaCroix, A. Z. (1996). Association of body mass in-
Medicine, 149, 1514–1520. dex with reinfarction and survival after first myocardial infarction in
9
9
5
5
85. Simonson, D. C., & Dzau, V. J. (1991). Workshop IX: Lipids, insulin, women. Journal of Women’s Health, 5, 433–444.
e
e
diabetes. American Journal of Medicine, 90(Suppl. 2A), 85S–86S. 108. Harris, T., Cook, E. F., Garrison, R. et al. (1988). Body mass index and
86. Manson, J. E., Colditz, G. A., Stampfer, M. J., et al. (1990). A prospec- mortality among nonsmoking older persons: The Framingham Heart
9
tive study of obesity and risk of coronary heart disease in women. New Study. JAMA, 259, 1520–1524.
9
England Journal of Medicine, 322, 882–889. 109. Li, T. Y., Rana, J. S., Manson, J. E., et al. (2006). Obesity as compared
2
2
87. Diabetes Control and Complications Trial Research Group. (1993). The with physical activity in predicting risk of coronary heart disease in
effect of intensive treatment of diabetes on the development and pro- women. Circulation, 113(4), 499–506.
gression of long-term complications in insulin-dependent diabetes melli- 110. Rexrode, K. M., Buring, J. E., & Manson, J. E. (2001). Abdominal and
tus: The Diabetes Control and Complications Trial Research Group. total adiposity and risk of coronary heart disease in men. International
New England Journal of Medicine, 329, 977–986. Journal of Obesity and Related Metabolic Disorders, 25(7), 1047–1056.
9
9
88. Gaede, P., Vedel, P., Larsen, N., et al. (2003). Multifactorial intervention 111. Zhu, S., Wang, Z., Heshka, S., et al. (2002). Waist circumference and
and cardiovascular disease in patients with type 2 diabetes. New England obesity-associated risk factors among whites in the third National Health
8
Journal of Medicine, 348, 383–393. and Nutrition Examination Survey: Clinical action thresholds. American
6
6
89. Grundy, S. M., Garber, A., Goldberg, R., et al. (2002). Diabetes and car- Journal of Clinical Nutrition, 76(4), 743.
diovascular disease writing group IV: Lifestyle and medical management 112. Beard, D. M., Fuster, V., & Annergers, J. F. (1984). Reproductive history
5
of risk factors. Circulation, 105, e153–e158. in women with coronary heart disease: A case-control study. American
5
0
90. Buse, J. B., Ginsberg, H.N., Bakris G. L., et al. (2007). Primary preven- Journal of Epidemiology, 120, 108–114.
0
tion of cardiovascular diseases in people with diabetes mellitus: A scien- 113. Palmer, J. R., Rosenberg, L., & Shapiro, S. (1992). Reproductive factors
tific statement from the American Heart Association and the American and risk of myocardial infarction. American Journal of Epidemiology, 136,
6
6
Diabetes Association. Diabetes Care, 30(1), 162–172. 408–416.
91. Diabetes Prevention Program Research Group. (2002). Reduction in the 114. Colditz, G. A., Willett, W. C., Stampfer, M. J., et al. (1987). A prospec-
incidence of type 2 diabetes with lifestyle intervention or metformin. tive study of age at menarche, parity, age at first birth, and coronary heart
New England Journal of Medicine, 346, 393–403. disease in women. American Journal of Epidemiology, 126, 861–870.
6
6
92. Tuomilehto, J., Lindstrom, J., Eriksson, J. G., et al. (2001). Finnish Di- 115. Stampfer, M. J., Colditz, G. A., & Willett, W. C. (1990). Menopause and
abetes Prevention Study Group. Prevention of type 2 diabetes mellitus by heart disease: A review. Annals of the New York Academy of Science, 592,
2
2
changes in lifestyle among subjects with impaired glucose tolerance. New 193–203.
England Journal of Medicine, 344(18), 1343–1350. 116. Stampfer, M. J., & Colditz, G. A. (1991). Estrogen replacement therapy
4
4
93. Ramachandran, A., Snehalatha, C., Mary, S., et al. (2006). The Indian and coronary heart disease: A quantitative assessment of the epidemio-
0
0
Diabetes Prevention Programme shows that lifestyle modification and logic evidence. Preventive Medicine, 20, 47–63.